Phase II study of biweekly administration of docetaxel and irinotecan in patients with refractory or relapsed advanced non-small cell lung cancer

Author： Hirose Takashi   Shirai Takao   Ishida Hiroo   Ando Kohichi   Sugiyama Tomohide   Kusumoto Sojiro   Hosaka Takamichi   Nakashima Masanao   Ohmori Tohru   Adachi Mitsuru  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.60, Iss.2, 2007-07, pp. : 267-274

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Biweekly docetaxel-irinotecan with filgrastim support in pretreated breast and non-small-cell lung cancer patients. A phase I study

By Frasci Giuseppe   Comella Pasquale   Thomas Renato   Bonito Maurizio   Lapenta Liliana   Capasso Immacolata   Botti Gerardo   Vallone Paolo   Rosa Vincenzo   D'Aiuto Giuseppe   Comella Giuseppe  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 1, 2004-01 ,pp. : 25-32

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of S-1, a novel oral fluoropyrimidine, and biweekly administration of docetaxel for previously treated advanced non-small-cell lung cancer

By Oki Yasunari   Hirose Takashi   Yamaoka Toshimitsu   Kusumoto Sojiro   Shirai Takao   Sugiyama Tomohide   Okuda Kentaro   Nakashima Masanao   Murata Yasunori   Ohmori Tohru   Adachi Mitsuru  

Cancer Chemotherapy and Pharmacology, Vol. 67, Iss. 4, 2011-04 ,pp. : 791-797

Springer Publishing Company

Access to resources Recommend Favorite

A Phase II NCCTG Study of Irinotecan and Docetaxel in Previously Treated Patients with Non-Small Cell Lung Cancer

By Molina Julian   Nikcevich Daniel   Hillman Shauna   Geyer Susan   Drevyanko Timothy   Jett James   Verdirame Joseph   Tazelaar Henry   Rowland Kendrith   Wos Edward   Kutteh Leila   Nair Suresh   Fitch Tom   Flynn Patrick   Stella Philip   Adjei Alex  

Cancer Investigation, Vol. 24, Iss. 4, 2006-07 ,pp. : 382-389

Informa Healthcare

Access to resources Recommend Favorite

Phase II study of irinotecan and amrubicin in patients with relapsed non-small cell lung cancer: Okayama Lung Cancer Study Group Trial 0402

By Nogami Naoyuki   Hotta Katsuyuki   Segawa Yoshihiko   Takigawa Nagio   Hosokawa Shinobu   Oze Isao   Fujii Masanori   Ichihara Eiki   Shibayama Takuo   Tada Atsuhiko   Hamada Noboru   Uno Masatoshi   Tamaoki Akihiko   Kuyama Shoichi   Ikeda Genyo   Osawa Masahiro   Takata Saburo   Tabata Masahiro   Tanimoto Mitsune   Kiura Katsuyuki  

Acta Oncologica, Vol. 51, Iss. 6, 2012-07 ,pp. : 768-773

Informa Healthcare

Access to resources Recommend Favorite

A phase II study of docetaxel and vinorelbine combination chemotherapy in patients with advanced non-small cell lung cancer

By Bennouna J.   Monnier A.   Riviere A.   Milleron B.   Lemarie E.   Trillet-Lenoir V.   Soussan-Lazard K.   Berille J.   Douillard J.Y.  

European Journal of Cancer, Vol. 36, Iss. 9, 2000-06 ,pp. : 1107-1112

Elsevier

Access to resources Recommend Favorite